Monday, 20 April 2020

There's More to Gilead Sciences' Remdesivir Data Than Meets the Eye - Motley Fool

Posted by hamad on 17:52 No comments
  1. There's More to Gilead Sciences' Remdesivir Data Than Meets the Eye  Motley Fool
  2. Drug used to treat Ebola may help COVID-19 patients, preliminary results suggest  Livescience.com
  3. BMO downgrades Gilead over concerns about commercial promise of remdesivir  MarketWatch
  4. Gilead Stock Rallied on Covid-19 Drug Hopes. This Is as Good as It Gets, Analysts Say.  Barron's
  5. Gilead Sciences: Possible COVID-19 Treatment Already Priced in the Stock, Says Analyst  Yahoo Finance
  6. View Full Coverage on Google News


from Top stories - Google News https://ift.tt/3apilP2

No comments :

Post a Comment

Subscribe to: Post Comments ( Atom )

Recent Posts

Like us

Contact

Name

Email *

Message *